Načítá se...
Targeting the NLRP3 Inflammasome via BTK
The NLRP3 inflammasome represents a critical inflammatory machinery driving pathology in many acute (e. g., myocardial infarction or stroke) and chronic (Alzheimer's disease, atherosclerosis) human disorders linked to the activity of IL-1 cytokines. Although the therapeutic potential of NLRP3 i...
Uloženo v:
| Vydáno v: | Front Cell Dev Biol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947255/ https://ncbi.nlm.nih.gov/pubmed/33718366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.630479 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|